The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thanks for posting
Will try and have a listen later re conference call
Looking forward to it
Anyone listening in here?
17p
I may be wrong but given results are to January any additional activity like funding from lifearc would need to be provided in a separate RNS.
Webcast later today may give some extra info on what is currently going on regarding lifearc. My feeling is that we may be getting more news fairly soon.
Nothing really new in there...one major piece missing however is the funding allocations for Covid research by LifeArc which is now overdue..10million funds for that...tes webcast may give some more updates
Didn’t do ODX holders any harm yesterday!!!!
Wow, selling prior to investor webcast. Brave.
Surely topping up now!
Sellers are getting absolutely robbed in the opening few minutes. Trading 101 - don't sell in the opening 15 minutes as the MM's will have your pants down.
I'm very glad we are just moving forwards as planned and don't have some half baked, temporary COV link.
Our re rate is well over due and a long way to go IMO.
Strong results. This is a company that is quietly going about its business of drug discovery. Considerable potential to be realised imo. This is not a Covid-19 Icarus type stock that will fly too close to the sun & then crash to earth. More a buy & hold for steady appreciation. So "Hare & Tortoise" - and who won the race?
I'm glad we are not on the COVID band wagon, as the vast majority of those shoes will spike then fall just as quickly.
Something much more solid going on here. tick tock..
patience needed yes, but have a look at what's in the pipeline and what we do.
News on the next molecule could drop any time now, and in view of recent SP movement it could be on its way.
Lmao, fund raise? Was done not very long ago hence the £5.5m in cash.
What there is here is a huge amount of R&D investment and a pipe line of very strong projects on the go with some very big players in the industry. No covid band wagon jumping which to be fair, i was may be expecting!
The BOD bought at 15p and then at 60p range before that. skin in the game, which can't be said for the vast majority of other shares.
That's just incorrect.
Clearly we have stuff going on lol, its been a while since we got news of a new molecule, they must be well into this process now.
You have to remember what the value was recently before the crash in SP. 50p and 90p zone before that.
If we had nothing going on we would not be at 20p we would be at zero, so move on clown
Over £5m in cash as of January so I doubt it will happen anytime soon. Given results are to January there may have grants inbound that can only be announced once agreed/received (from the likes of lifearc for C19?)
Nothing going on here other than an imminent fundraise.
https://www.investegate.co.uk/c4x-discovery--c4xd-/rns/interim-results/202004290700042360L/
You have one
Volume picking up. Gap to 40p but can see this much higher
This is what Edinburgh University is doing with their 2 million allocation from LifeArc...
Let us know you agree to cookies
We use cookies to give you the best online experience. Please let us know if you agree to all of these cookies.
Accept Reject
BBC News
menu
Coronavirus: Drugs to be tested on lungs of ICU patients
16 April 2020 Health
Share this with Email Share this with Facebook Share this with Twitter Share this with Whatsapp
Image copyrightUNIVERSITY OF BATHThe region of the lung damaged by the virus
Medicines will be tested in the lungs of patients in intensive care in order to fast track new treatments for Covid-19.
The "STOPCOVID" initiative at Edinburgh University is to use existing drugs provided by leading drug companies and smaller biotech firms.
The team has unique expertise in administering drugs in the lung and assessing if tissues heal.
The project has been given the backing of top scientific and medical advisors.
The system involves sending medicines to the outermost portion of the lung, which are the areas that are damaged and inflamed among those with severe symptoms of Covid-19.
The researchers are also able to see whether the drug is working using a fibre-optic camera inserted into the lung and so-called "chemical probes" inserted into the area, which indicate whether the damaged tissue is becoming less inflamed.
'Stop lung inflammation'
The system was developed as part of a research project to treat a variety of lung disorders. But, according to Prof Kev Dhaliwal, of Edinburgh University, it is ideal for testing new drugs to combat the current pandemic.
"Currently 50% of patients who are admitted to intensive care with the Covid-19 die. The key to improving those odds is to stop that lung inflammation from occurring is absolutely crucial," he told BBC News.
The team has a list of anti-inflammatory and anti-microbial drugs that it plans to test on those in critical care. Many of those are involved are clinicians treating Covid-19 patients.
"It's been humbling to see the response," says Prof Dhaliwal. "No one is asking for any extra money - they just voluntarily got on with it - working all hours seven days a week."
"We have an incredible scientific community and they are galvanizing themselves to slow down this dreadful disease and save lives."
Up to 150 researchers are involved in the study. As well as clinicians, the team also includes scientists and engineers who have dropped their normal projects to work on the STPCOVID project.
"Normally it would take months to get a single drug into a clinical trail. We are trying to do this in weeks," Prof Dhaliwal says.
"We want to get our results out there as fast as possible so that any promising drugs can be put into clinical trials straight away."
Scientists working together
The team believes new therapies could be discovered and implemented before a vaccine becomes widely available by repurposing medicines for other con
Let them ride , keep a finger in all the Pies ;-) opportunity knocks once ,
Fingers crossed. I finally pressed the buy button after a bit of reading this afternoon. Big potential and given the likes of NCYT and HEMO have seen astronomical rises it wouldn't surprise me to see C4X do the same. A double whammy of positive results RNS and interaction with lifearc would be brilliant.
hopefully there will be some good news reported tomorrow